AU2003259689A1 - 3-imino-2-indolones for the treatment of depression and/or anxiety - Google Patents
3-imino-2-indolones for the treatment of depression and/or anxietyInfo
- Publication number
- AU2003259689A1 AU2003259689A1 AU2003259689A AU2003259689A AU2003259689A1 AU 2003259689 A1 AU2003259689 A1 AU 2003259689A1 AU 2003259689 A AU2003259689 A AU 2003259689A AU 2003259689 A AU2003259689 A AU 2003259689A AU 2003259689 A1 AU2003259689 A1 AU 2003259689A1
- Authority
- AU
- Australia
- Prior art keywords
- indolones
- imino
- anxiety
- depression
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- DPUCWQUWEJBKPK-UHFFFAOYSA-N 3-aminoindol-2-one Chemical class C1=CC=C2C(=N)C(=O)NC2=C1 DPUCWQUWEJBKPK-UHFFFAOYSA-N 0.000 title 1
- 208000019901 Anxiety disease Diseases 0.000 title 1
- 208000020401 Depressive disease Diseases 0.000 title 1
- 230000036506 anxiety Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21537402A | 2002-08-07 | 2002-08-07 | |
| US10/215,374 | 2002-08-07 | ||
| PCT/US2003/024867 WO2004014854A1 (en) | 2002-08-07 | 2003-08-07 | 3-imino-2-indolones for the treatment of depression and/or anxiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003259689A1 true AU2003259689A1 (en) | 2004-02-25 |
Family
ID=31714271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003259689A Abandoned AU2003259689A1 (en) | 2002-08-07 | 2003-08-07 | 3-imino-2-indolones for the treatment of depression and/or anxiety |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003259689A1 (en) |
| TW (1) | TW200410937A (en) |
| WO (1) | WO2004014854A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7642281B2 (en) | 2002-08-07 | 2010-01-05 | Helicon Therapeutics, Inc. | Indolone compounds useful to treat cognitive impairment |
| CZ2008423A3 (en) * | 2005-12-09 | 2009-08-05 | Helicon Therapeutics, Inc. | Indolone compounds useful to treat cognitive impairment |
| KR20120093408A (en) * | 2009-12-04 | 2012-08-22 | 에프. 호프만-라 로슈 아게 | Tetrahydroquinoline indole derivatives as monoamine reuptake inhibitors |
| US8277842B1 (en) | 2012-01-20 | 2012-10-02 | Dart Neuroscience (Cayman) Ltd. | Enteric-coated HT-2157 compositions and methods of their use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459274A (en) * | 1994-05-13 | 1995-10-17 | Hoechst-Roussel Pharmaceuticals Inc. | Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines |
| GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
-
2003
- 2003-08-07 TW TW92121747A patent/TW200410937A/en unknown
- 2003-08-07 AU AU2003259689A patent/AU2003259689A1/en not_active Abandoned
- 2003-08-07 WO PCT/US2003/024867 patent/WO2004014854A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004014854A1 (en) | 2004-02-19 |
| TW200410937A (en) | 2004-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003217870A1 (en) | Pini-modulating compounds and methods of use thereof | |
| AU2003225669A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003225668A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003213673A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003275311A1 (en) | Solid micro-perforators and methods of use | |
| PL375691A1 (en) | Imidazolopyridines and methods of making and using the same | |
| AU2002320456A1 (en) | Removable stent and method of using the same | |
| AU2002314466A1 (en) | Withasol and methods of use | |
| AU2003280298A1 (en) | Methods for the biological treatment of gas | |
| AU2003279442A1 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
| AU2003286737A1 (en) | Apparatuses and methods for the manufacture and placement of truss assemblies | |
| AU2003258145A1 (en) | Substituted phenylindoles for the treatment of hiv | |
| AU2003267241A1 (en) | Method for treating depression and/or anxiety | |
| AU2003297612A1 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
| AU2002363938A1 (en) | Methods and use of motoneuronotropic factors | |
| AU2003287802A1 (en) | Palpometer and methods of use thereof | |
| AU2003266965A1 (en) | Use of carboxamides for the treatment of tinnitus | |
| AU2003259689A1 (en) | 3-imino-2-indolones for the treatment of depression and/or anxiety | |
| AU5565401A (en) | Materials and methods for the treatment of depression | |
| AU2003268939A1 (en) | Bisphosphonates for the treatment of antheroscleorosis and devices comprising them | |
| AU2003279800A8 (en) | Sulfatases and methods of use thereof | |
| GB0300078D0 (en) | Composition for the treatment of HIV and AIDS | |
| AU2002361488A1 (en) | Field and background of the invention | |
| WO2005042707A9 (en) | Taspasel 1 and methods of use | |
| IL149705A0 (en) | Combination treatment for depression and anxiety |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |